Radiation Oncology Market Size, Share & Trends Analysis Report By Type (External Beam Radiation Therapy, Internal Beam Radiation Therapy), By Technology, By Application, By Region, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology And Scope
1.1 Market Segmentation And Scope
1.1.1 Segment Scope
1.1.2 Regional Scope
1.1.3 Estimates And Forecast Timeline:
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database:
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 List Of Secondary Sources
1.8 List Of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Market Definitions
3.3 Key Opportunities Prioritized
3.4 Market Dynamic Analysis
3.4.1 Rising Adoption Of Radiotherapy
3.4.2 Technological Advancements In Radiotherapy
3.4.3 Rising Prevalence Of Cancer
3.4.4 Increase In Healthcare Expenditure
3.4.5 Increasing APPLICATION OF Radiopharmaceuticals
3.5 Market Restraint Analysis
3.5.1 Lack Of Skilled Radiotherapy Professionals
3.5.2 Inadequate Radiation Infrastructure
3.5.3 Adverse Effects Of Radiotherapy
3.6 Business Environment Analysis
3.6.1 SWOT分析;通过因素(政治和法律,Economic And Technological)
3.6.2 Porter’s Five Forces Analysis
Chapter 4 Radiation Oncology Market - Segment Analysis, By Type, 2018 - 2030 (USD Million)
4.1 Radiation Oncology Market: Type Movement Analysis
4.2 External Beam Radiation Therapy
4.2.1 External Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
4.2.2 Electron-Emitting High Energy Linear Accelerators
4.2.2.1 Electron-Emitting High Energy Linear Accelerators Market, 2018 - 2030 (USD Million)
4.2.3 Compact Advanced Radiotherapy Systems
4.2.3.1 Compact Advanced Radiotherapy Systems Market, 2018 - 2030 (USD Million)
4.2.3.2 Cyberknife
4.2.3.2.1 Cyberknife Market, 2018 - 2030 (USD Million)
4.2.3.3 Gamma Knife
4.2.3.3.1 Gamma Knife Market, 2018 - 2030 (USD Million)
4.2.3.4 Tomotherapy
4.2.3.4.1 Tomotherapy Compact Market, 2018 - 2030 (USD Million)
4.2.4 Proton Therapy
4.2.4.1 Proton Therapy Market, 2018 - 2030 (USD Million)
4.2.4.2 Cyclotron
4.2.4.2.1 Cyclotron Market, 2018 - 2030 (USD Million)
4.2.4.3 Synchrotron
4.2.4.3.1 Synchrotron Market, 2018 - 2030 (USD Million)
4.3 Internal Beam Radiation Therapy
4.3.1 Internal Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
4.3.2 Brachytherapy
4.3.2.1 Brachytherapy Market, 2018 - 2030 (USD Million)
4.3.2.2 Seeds
4.3.2.2.1 Seeds Market, 2018 - 2030 (USD Million)
4.3.2.3 Applicators And After-Loaders
4.3.2.3.1 Applicators And After-Loaders Market, 2018 - 2030 (USD Million)
4.3.2.4 Electronic Brachytherapy
4.3.2.4.1电子近距离放射疗法市场,2018年2030 (USD Million)
4.3.3 Systemic Beam Radiation Therapy
4.3.3.1 Systemic Beam Radiation Therapy Market, 2018 - 2030 (USD Million)
4.3.4 Others
4.3.4.1 Others Market, 2016-2028 (USD Million)
Chapter 5 Radiation Oncology Market - Segment Analysis, By Technology, 2018 - 2030 (USD Million)
5.1 Radiation Oncology Market: Technology Movement Analysis
5.2 External Beam Radiation Therapy (EBRT)
5.2.1 EBRT Market, 2018 - 2030 (USD Million)
5.2.2 Image-Guided Radiation Therapy (IGRT)
5.2.2.1 IGRT Market, 2018 - 2030 (USD Million)
5.2.3 Intensity Modulated Radiotherapy (IMRT)
5.2.3.1 IMRT Market, 2018 - 2030 (USD Million)
5.2.4立体定向放射治疗
5.2.4.1 Stereotactic Radiotherapy Market, 2018 - 2030 (USD Million)
5.2.5 Proton Beam Therapy
5.2.5.1 Proton Beam Therapy Market, 2018 - 2030 (USD Million)
5.2.6 3D Conformal Radiotherapy (3D-CRT)
5.2.6.1 3D-CRT Market, 2018 - 2030 (USD Million)
5.2.7 Volumetric Modulated Arc Therapy (VMAT)
5.2.7.1 VMAT Market, 2018 - 2030 (USD Million)
5.3 Brachytherapy
5.3.1 Brachytherapy Market, 2018 - 2030 (USD Million)
5.3.2 Low Dose Rate (LDR) Brachytherapy
5.3.2.1 LDR Brachytherapy Market, 2018 - 2030 (USD Million)
5.3.3 High Dose Rate (HDR) Brachytherapy
5.3.3.1 HDR Brachytherapy Market, 2018 - 2030 (USD Million)
Chapter 6 Radiation Oncology Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)
6.1 Radiation Oncology Market: Application Movement Analysis
6.2 External Beam Radiation Therapy (EBRT)
6.2.1 Prostate Cancer
6.2.1.1 Prostate Cancer Market, 2018 - 2030 (USD Million)
6.2.2 Breast Cancer
6.2.2.1 Breast Cancer Market, 2018 - 2030 (USD Million)
6.2.3 Lung Cancer
6.2.3.1 Lung Cancer Market, 2018 - 2030 (USD Million)
6.2.4 Head And Neck Cancer
6.2.4.1 Head And Neck Cancer Market, 2018 - 2030 (USD Million)
6.2.5 Colorectal Cancer
6.2.5.1 Colorectal Cancer Market, 2018 - 2030 (USD Million)
6.2.6 Others
6.2.6.1 Others Market, 2018 - 2030 (USD Million)
6.3 Internal Beam Radiation Therapy
6.3.1 Prostate Cancer
6.3.1.1 Prostate Cancer Market, 2018 - 2030 (USD Million)
6.3.2 Gynecologic Cancer
6.3.2.1 Gynecologic Cancer Market, 2018 - 2030 (USD Million)
6.3.3 Breast Cancer
6.3.3.1 Breast Cancer Market, 2018 - 2030 (USD Million)
6.3.4 Cervical Cancer
6.3.4.1 Cervical Cancer Market, 2018 - 2030 (USD Million)
6.3.5 Penile Cancer
6.3.5.1 Penile Cancer Market, 2018 - 2030 (USD Million)
6.3.6 Others
6.3.6.1 Others Market, 2018 - 2030 (USD Million)
Chapter 7 Radiation Oncology Market - Segment Analysis, By Region, 2018 - 2030 (USD Million)
7.1 Definition & Scope
7.2 North America
7.2.1 North America, SWOT Analysis
7.2.2 U.S.
7.2.2.1 U.S. Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.2.2 Key Country Dynamics
7.2.2.3 Target Disease Prevalence
7.2.2.4 Competitive Scenario
7.2.2.5 Regulatory Framework
7.2.2.6 Reimbursement Scenario
7.2.3 Canada
7.2.3.1 Canada Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.2.3.2 Key Country Dynamics
7.2.3.3 Target Disease Prevalence
7.2.3.4 Competitive Scenario
7.2.3.5 Regulatory Framework
7.2.3.6 Reimbursement Scenario
7.3 Europe
7.3.1 Europe, SWOT Analysis
7.3.2 U.K.
7.3.2.1 U.K. Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.2.2 Key Country Dynamics
7.3.2.3 Target Disease Prevalence
7.3.2.4 Competitive Scenario
7.3.2.5 Regulatory Framework
7.3.2.6 Reimbursement Scenario
7.3.3 Germany
7.3.3.1 Germany Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.3.2 Key Country Dynamics
7.3.3.3 Target Disease Prevalence
7.3.3.4 Competitive Scenario
7.3.3.5 Regulatory Framework
7.3.3.6 Reimbursement Scenario
7.3.4 France
7.3.4.1 France Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.4.2 Key Country Dynamics
7.3.4.3 Target Disease Prevalence
7.3.4.4 Competitive Scenario
7.3.4.5 Regulatory Framework
7.3.4.6 Reimbursement Scenario
7.3.5 Italy
7.3.5.1 Italy Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.5.2 Key Country Dynamics
7.3.5.3 Target Disease Prevalence
7.3.5.4 Competitive Scenario
7.3.5.5 Regulatory Framework
7.3.5.6 Reimbursement Scenario
7.3.6 Spain
7.3.6.1 Spain Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.6.2 Key Country Dynamics
7.3.6.3 Target Disease Prevalence
7.3.6.4 Competitive Scenario
7.3.6.5 Regulatory Framework
7.3.6.6 Reimbursement Scenario
7.3.7 Sweden
7.3.7.1 Sweden Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.7.2 Key Country Dynamics
7.3.7.3 Target Disease Prevalence
7.3.7.4 Competitive Scenario
7.3.7.5 Regulatory Framework
7.3.7.6 Reimbursement Scenario
7.3.8 Denmark
7.3.8.1 Denmark Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.8.2 Key Country Dynamics
7.3.8.3 Target Disease Prevalence
7.3.8.4 Competitive Scenario
7.3.8.5 Regulatory Framework
7.3.8.6 Reimbursement Scenario
7.3.9 Norway
7.3.9.1 Norway Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.3.9.2 Key Country Dynamics
7.3.9.3 Target Disease Prevalence
7.3.9.4 Competitive Scenario
7.3.9.5 Regulatory Framework
7.3.9.6 Reimbursement Scenario
7.3.10 Rest Of Europe
7.3.10.1 Rest Of Europe Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Asia Pacific, SWOT Analysis
7.4.2 India
7.4.2.1 India Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.2.2 Key Country Dynamics
7.4.2.3 Target Disease Prevalence
7.4.2.4 Competitive Scenario
7.4.2.5 Regulatory Framework
7.4.2.6 Reimbursement Scenario
7.4.3 China
7.4.3.1 China Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.3.2 Key Country Dynamics
7.4.3.3 Target Disease Prevalence
7.4.3.4 Competitive Scenario
7.4.3.5 Regulatory Framework
7.4.3.6 Reimbursement Scenario
7.4.4 Japan
7.4.4.1 Japan Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.4.2 Key Country Dynamics
7.4.4.3 Target Disease Prevalence
7.4.4.4 Competitive Scenario
7.4.4.5 Regulatory Framework
7.4.4.6 Reimbursement Scenario
7.4.5 Australia
7.4.5.1 Australia Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.5.2 Key Country Dynamics
7.4.5.3 Target Disease Prevalence
7.4.5.4 Competitive Scenario
7.4.5.5 Regulatory Framework
7.4.5.6 Reimbursement Scenario
7.4.6 South Korea
7.4.6.1 South Korea Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.6.2 Key Country Dynamics
7.4.6.3 Target Disease Prevalence
7.4.6.4 Competitive Scenario
7.4.6.5 Regulatory Framework
7.4.6.6 Reimbursement Scenario
7.4.7 THAILAND
7.4.7.1 Thailand Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.4.7.2 Key Country Dynamics
7.4.7.3 Target Disease Prevalence
7.4.7.4 Competitive Scenario
7.4.7.5 Regulatory Framework
7.4.7.6 Reimbursement Scenario
7.4.8 Rest Of APAC
7.4.8.1 Rest Of APAC Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5 Latin America
7.5.1 Latin America, SWOT Analysis
7.5.2 Mexico
7.5.2.1 Mexico Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5.2.2 Key Country Dynamics
7.5.2.3 Target Disease Prevalence
7.5.2.4 Competitive Scenario
7.5.2.5 Regulatory Framework
7.5.2.6 Reimbursement Scenario
7.5.3 Brazil
7.5.3.1 Brazil Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5.3.2 Key Country Dynamics
7.5.3.3 Target Disease Prevalence
7.5.3.4 Competitive Scenario
7.5.3.5 Regulatory Framework
7.5.3.6 Reimbursement Scenario
7.5.4 Argentina
7.5.4.1 Argentina Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.5.4.2 Key Country Dynamics
7.5.4.3 Target Disease Prevalence
7.5.4.4 Competitive Scenario
7.5.4.5 Regulatory Framework
7.5.4.6 Reimbursement Scenario
7.5.5 Rest Of LATAM
估计和Forecas 7.5.5.1其他拉丁美洲市场t, 2018 - 2030 (USD Million)
7.6 MEA
7.6.1 Middle East & Africa, SWOT Analysis
7.6.2 South Africa
7.6.2.1 South Africa Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.2.2 Key Country Dynamics
7.6.2.3 Target Disease Prevalence
7.6.2.4 Competitive Scenario
7.6.2.5 Regulatory Framework
7.6.2.6 Reimbursement Scenario
7.6.3 Saudi Arabia
7.6.3.1 Saudi Arabia Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.3.2 Key Country Dynamics
7.6.3.3 Target Disease Prevalence
7.6.3.4 Competitive Scenario
7.6.3.5 Regulatory Framework
7.6.3.6 Reimbursement Scenario
7.6.4 UAE
7.6.4.1 UAE Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.4.2 Key Country Dynamics
7.6.4.3 Target Disease Prevalence
7.6.4.4 Competitive Scenario
7.6.4.5 Regulatory Framework
7.6.4.6 Reimbursement Scenario
7.6.5 Kuwait
7.6.5.1 Kuwait Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.5.2 Key Country Dynamics
7.6.5.3 Target Disease Prevalence
7.6.5.4 Competitive Scenario
7.6.5.5 Regulatory Framework
7.6.5.6 Reimbursement Scenario
7.6.6 Rest Of MEA
7.6.6.1 Rest Of MEA Market Estimates And Forecast, 2018 - 2030 (USD Million)
Chapter 8 Competitive Landscape
8.1 Public Companies
8.1.1 Company Market Position Analysis
8.1.2 Competitive Dashboard Analysis
8.1.3 Strategic Framework
8.2 Private Companies
8.2.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
8.2.2 Regional Network Map
8.3 Company Profiles
8.3.1 Varian Medical Systems, Inc. (A Part Of Siemens Healthineers)
8.3.1.1 Company Overview
8.3.1.2 Financial Performance
8.3.1.3 Product Benchmarking
8.3.1.4 Strategic Initiatives
8.3.2 Elekta AB
8.3.2.1 Company Overview
8.3.2.2 Financial Performance
8.3.2.3 Product Benchmarking
8.3.2.4 Strategic Initiatives
8.3.3 Accuray Incorporated
8.3.3.1 Company Overview
8.3.3.2 Financial Performance
8.3.3.3 Product Benchmarking
8.3.3.4 Strategic Initiatives
8.3.4 Ion Beam Applications (IBA).
8.3.4.1 Company Overview
8.3.4.2 Financial Performance
8.3.4.3 Product Benchmarking
8.3.4.4 Strategic Initiatives
8.3.5 BD (Becton, Dickinson And Company)
8.3.5.1 Company Overview
8.3.5.2 Financial Performance
8.3.5.3 Product Benchmarking
8.3.5.4 Strategic Initiatives
8.3.6 Isoray Medical
8.3.6.1 Company Overview
8.3.6.2 Financial Performance
8.3.6.3 Product Benchmarking
8.3.6.4 Strategic Initiatives
8.3.7 Mevion Medical Systems
8.3.7.1 Company Overview
8.3.7.2 Product Benchmarking
8.3.7.3 Strategic Initiatives
8.3.8 Nordion Inc.
8.3.8.1 Company Overview
8.3.8.2 Product Benchmarking
8.3.8.3 Strategic Initiatives
8.3.9 NTP Radioisotopes SOC Ltd.
8.3.9.1 Company Overview
8.3.9.2 Financial Performance
8.3.9.3 Product Benchmarking
8.3.9.4 Strategic Initiatives
8.3.10 Curium
8.3.10.1 Company Overview
8.3.10.2 Product Benchmarking
8.3.10.3 Strategic Initiatives
8.3.11 VIEWRAY TECHNOLOGIES, INC.
8.3.11.1 Company Overview
8.3.11.2 Financial Performance
8.3.11.3 Product Benchmarking
8.3.11.4 Strategic Initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviation
Table 3 List of Parameters
Table 4 List of Distributors
Table 5 Global Radiation Oncology Market, By Region, 2018 - 2030 (USD Million)
Table 6 Global Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 7 Global Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 8 Global Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 9 North America Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
Table 10 North America Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 11 North America Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 12 North America Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 13 U.S. Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 14 U.S. Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 15 U.S. Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 16 Canada Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 17 Canada Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 18 Canada Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 19 Europe Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
Table 20 Europe Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 21 Europe Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 22 Europe Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 23 Germany Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 24 Germany Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 25 Germany Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 26 U.K. Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 27 U.K. Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 28 U.K. Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 29 France Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 30 France Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 31 France Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 32 Italy Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 33 Italy Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 34 Italy Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 35 Spain Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 36 Spain Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 37 Spain Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 38 Denmark Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 39 Denmark Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 40 Denmark Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 41 Sweden Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 42 Sweden Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 43 Sweden Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 44 Norway Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 45 Norway Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
表46挪威辐射Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 50 Asia Pacific Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 51 Japan Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 52 Japan Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 53 Japan Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 54 China Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 55 China Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 56 China Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 57 India Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 58 India Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 59 India Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 60 South Korea Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 61 South Korea Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 62 South Korea Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 63 Australia Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 64 Australia Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 65 Australia Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 66 Thailand Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 67 Thailand Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 68 Thailand Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 69 Latin America Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
Table 70 Latin America Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 71 Latin America Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 72 Latin America Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 73 Brazil Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 74 Brazil Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 75 Brazil Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 76 Mexico Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 77 Mexico Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 78 Mexico Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 79 Argentina Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 80 Argentina Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 81 Argentina Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa Radiation Oncology Market, By Country, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 84 Middle East & Africa Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 85 Middle East & Africa Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
表88年沙特阿拉伯放射肿瘤学市场,By Application, 2018 - 2030 (USD Million)
Table 89 South Africa Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 90 South Africa Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 91 South Africa Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 92 UAE Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 93 UAE Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 94 UAE Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)
Table 95 Kuwait Radiation Oncology Market, By Type, 2018 - 2030 (USD Million)
Table 96 Kuwait Radiation Oncology Market, By Technology, 2018 - 2030 (USD Million)
Table 97 Kuwait Radiation Oncology Market, By Application, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Radiation oncology market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Radiation oncology market snapshot
Fig. 10 Radiation oncology market segmentation
Fig. 11 Radiation oncology market driver impact
Fig. 12 Radiation oncology market restraint impact
Fig. 13 Key market opportunities
Fig. 14 SWOT analysis, by factor (political & legal economic and technological)
Fig. 15 Porter’s five forces analysis
Fig. 16 Radiation oncology market: Type outlook and key takeaways
Fig. 17 Radiation oncology market: Type movement analysis
Fig. 18 External beam radiation therapy market, 2018 - 2030 (USD Million)
Fig. 19 Electron-emitting high energy linear accelerators market, 2018 - 2030 (USD Million)
Fig. 20 Compact advanced radiotherapy systems market, 2018 - 2030 (USD Million)
Fig. 21 CyberKnife market, 2018 - 2030 (USD Million)
Fig. 22 Gamma Knife market, 2018 - 2030 (USD Million)
Fig. 23 Tomotherapy market, 2018 - 2030 (USD Million)
Fig. 24 Proton therapy market, 2018 - 2030 (USD Million)
Fig. 25 Cyclotron market, 2018 - 2030 (USD Million)
Fig. 26 Synchrotron market, 2018 - 2030 (USD Million)
Fig. 27 Internal beam radiation therapy market, 2018 - 2030 (USD Million)
图28 Brachytherapy market, 2018 - 2030 (USD Million)
Fig. 29 Seeds market, 2018 - 2030 (USD Million)
Fig. 30 Applicators and after-loaders market, 2018 - 2030 (USD Million)
Fig. 31 Electronic brachytherapy market, 2018 - 2030 (USD Million)
Fig. 32 Systemic beam radiation therapy market, 2018 - 2030 (USD Million)
Fig. 33 Others market, 2016–2028 (USD Million)
Fig. 34 Radiation oncology market: External Beam Radiation Therapy (EBRT) technology outlook and key takeaways
Fig. 35 Radiation oncology market: External Beam Radiation Therapy (EBRT) technology movement analysis
Fig. 36 Radiation oncology market: Internal Beam Radiation Therapy (IBRT) technology movement analysis
Fig. 37 EBRT market, 2018 - 2030 (USD Million)
Fig. 38 IGRT market, 2018 - 2030 (USD Million)
Fig. 39 IMRT market, 2018 - 2030 (USD Million)
Fig. 40 Stereotactic radiotherapy market, 2018 - 2030 (USD Million)
Fig. 41 Proton beam therapy market, 2018 - 2030 (USD Million)
Fig. 42 3D-CRT market, 2018 - 2030 (USD Million)
Fig. 43 VMAT market, 2018 - 2030 (USD Million)
Fig. 44 Brachytherapy market, 2018 - 2030 (USD Million)
Fig. 45 LDR brachytherapy market, 2018 - 2030 (USD Million)
Fig. 46 HDR brachytherapy market, 2018 - 2030 (USD Million)
图47放射肿瘤学市场:应用程序look and key takeaways
Fig. 48 Radiation oncology market: EBRT Application movement analysis
Fig. 49 Prostate cancer market, 2018 - 2030 (USD Million)
Fig. 50 Breast cancer market, 2018 - 2030 (USD Million)
Fig. 51 Lung cancer market, 2018 - 2030 (USD Million)
Fig. 52 Head and neck cancer market, 2018 - 2030 (USD Million)
Fig. 53 Colorectal cancer market, 2018 - 2030 (USD Million)
Fig. 54 Others market, 2018 - 2030 (USD Million)
Fig. 55 Prostate cancer market, 2018 - 2030 (USD Million)
Fig. 56 Gynecologic cancer market, 2018 - 2030 (USD Million)
Fig. 57 Breast cancer market, 2018 - 2030 (USD Million)
Fig. 58 Cervical cancer market, 2018 - 2030 (USD Million)
Fig. 59 Penile cancer market, 2018 - 2030 (USD Million)
Fig. 60 Others market, 2018 - 2030 (USD Million)
Fig. 61 Radiation Oncology market: Regional outlook and key takeaways
Fig. 62 Radiation Oncology Market: Regional Movement Analysis
Fig. 63 North America
Fig. 64 North America radiation oncology market estimates and forecast, 2018 - 2030
Fig. 65 U.S.
Fig. 66 U.S. radiation oncology market estimates and forecast, 2018 - 2030
Fig. 67 Canada
Fig. 68 Canada radiation oncology market estimates and forecast, 2018 - 2030
Fig. 69 Europe
Fig. 70 Europe radiation oncology market estimates and forecast, 2018 - 2030
Fig. 71 Germany
Fig. 72 Germany radiation oncology market estimates and forecast, 2018 - 2030
Fig. 73 U.K.
Fig. 74 U.K. radiation oncology market estimates and forecast, 2018 - 2030
Fig. 75 France
Fig. 76 France radiation oncology market estimates and forecast, 2018 - 2030
Fig. 77 Italy
Fig. 78 Italy radiation oncology market estimates and forecast, 2018 - 2030
Fig. 79 Spain
Fig. 80 Spain radiation oncology market estimates and forecast, 2018 - 2030
Fig. 81 Denmark
Fig. 82 Denmark radiation oncology Market, 2018 - 2030 (USD Million)
Fig. 83 Sweden
Fig. 84 Sweden radiation oncology Market, 2018 - 2030 (USD Million)
Fig. 85 Norway
Fig. 86 Norway radiation oncology Market, 2018 - 2030 (USD Million)
Fig. 87 Rest of Europe
Fig. 88 Rest of Europe radiation oncology Market, 2018 - 2030 (USD Million
Fig. 89 Asia Pacific
Fig. 90 Asia Pacific radiation oncology market estimates and forecast, 2018 - 2030
Fig. 91 Japan
Fig. 92 Japan radiation oncology market estimates and forecast, 2018 - 2030
Fig. 93 China
Fig. 94 China radiation oncology market estimates and forecast, 2018 - 2030
Fig. 95 India
Fig. 96 India radiation oncology market estimates and forecast, 2018 - 2030
Fig. 97 South Korea
Fig. 98 South Korea radiation oncology market estimates and forecast, 2018 - 2030
Fig. 99 Australia
Fig. 100 Australia radiation oncology market estimates and forecast, 2018 - 2030
Fig. 101 Thailand
Fig. 102 Thailand radiation oncology Market, 2018 - 2030 (USD Million)
Fig. 103 Rest of APAC
Fig. 104 Rest of APAC radiation oncology Market, 2018 - 2030 (USD Million)
Fig. 105 Latin America
Fig. 106 Latin America radiation oncology market estimates and forecast, 2018 - 2030
Fig. 107 Brazil
Fig. 108 Brazil radiation oncology market estimates and forecast, 2018 - 2030
Fig. 109 Mexico
Fig. 110 Mexico radiation oncology market estimates and forecast, 2018 - 2030
Fig. 111 Argentina
Fig. 112 Argentina radiation oncology market estimates and forecast, 2018 - 2030
Fig. 113 Rest of LATAM
Fig. 114 Rest of LATAM radiation oncology Market, 2018 - 2030 (USD Million)
Fig. 115 Middle East & Africa
Fig. 116 Middle East and Africa radiation oncology market estimates and forecast, 2018 - 2030
Fig. 117 South Africa
Fig. 118 South Africa radiation oncology market estimates and forecast, 2018 - 2030
Fig. 119 Saudi Arabia
Fig. 120 Saudi Arabia radiation oncology market estimates and forecast, 2018 - 2030
Fig. 121 UAE
Fig. 122 UAE radiation oncology market estimates and forecast, 2018 - 2030
Fig. 123 Kuwait
Fig. 124 Kuwait radiation oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 125 Rest of MEA
Fig. 126 Rest of MEA radiation oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 127 Company market share analysis
Fig. 128 Company market position analysis (Total revenue)
Fig. 129 Company market position analysis (Profit margin)
Fig. 130 Competitive dashboard analysis
Fig. 131 Regional Network Map
Fig. 132 Strategic Framework